Schedule of Warrants Activity (Details) - $ / shares |
9 Months Ended | 12 Months Ended |
|---|---|---|
Sep. 30, 2021 |
Dec. 31, 2020 |
|
| Warrants | ||
| Warrants, Ending balance | 20,513,145 | 26,538,593 |
| Weighted Average Price, Ending balance | $ 1.36 | $ 1.08 |
| Warrants, Granted | 9,200,000 | |
| Weighted Average Price, Granted | $ 1.25 | |
| Warrants, Exercised | (2,472,573) | (5,680,114) |
| Weighted Average Price, Exercised | $ 0.91 | $ 0.91 |
| Warrants, Expired | (9,545,334) | |
| Weighted Average Price, Expired | $ 0.75 | |
| Warrants, Ending balance | 18,040,572 | 20,513,145 |
| Weighted Average Price, Ending balance | $ 1.42 | $ 1.36 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments expired in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|